| Lastest Insider Transactions Of BioAge Labs, Inc. ( BIOA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Chief Financial Officer | 2026-03-01 | Option Exercise | 3,542 | 4.38 | 15,514 | 2026-03-03 16:44:53 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2026-02-02 | Sell | 7,433 | 18.75 | 139,369 | 2026-02-03 16:26:11 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2026-02-02 | Option Exercise | 7,433 | 4.77 | 35,470 | 2026-02-03 16:26:11 |
| BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Chief Financial Officer | 2026-02-01 | Option Exercise | 3,541 | 4.38 | 15,510 | 2026-02-03 16:23:00 |
| BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Chief Financial Officer | 2026-01-16 | Option Exercise | 3,542 | 4.38 | 15,514 | 2026-01-21 16:20:56 |
| BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Chief Financial Officer | 2026-01-13 | Sell | 27,000 | 19.70 | 531,828 | 2026-01-15 16:22:20 |
| BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Chief Financial Officer | 2026-01-13 | Option Exercise | 27,000 | 8.39 | 226,530 | 2026-01-15 16:22:20 |
| BIOA | BioAge Labs, Inc. | Fortney Kristen | Chief Executive Officer | 2026-01-13 | Sell | 233,107 | 18.12 | 4,223,037 | 2026-01-15 16:20:14 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2026-01-02 | Sell | 7,433 | 12.85 | 95,490 | 2026-01-06 16:24:01 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2026-01-02 | Option Exercise | 7,433 | 4.77 | 35,470 | 2026-01-06 16:24:01 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2025-12-09 | Sell | 18,000 | 12.00 | 216,000 | 2025-12-11 16:21:15 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2025-12-09 | Option Exercise | 18,000 | 6.57 | 118,260 | 2025-12-11 16:21:15 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2025-12-04 | Sell | 68,897 | 10.19 | 701,909 | 2025-12-05 18:20:44 |
| BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Officer | 2025-12-04 | Option Exercise | 68,897 | 4.11 | 283,167 | 2025-12-05 18:20:44 |
| BIOA | BioAge Labs, Inc. | Hemrajani Rekha | Directior | 2024-04-17 | Buy | 3,000 | 18.00 | 54,000 | 2025-03-10 16:11:28 |
| BIOA | BioAge Labs, Inc. | Barton Shane | Principal Accounting Officer | 2024-09-27 | Buy | 2,632 | 18.00 | 47,376 | 2025-03-10 16:10:37 |
| BIOA | BioAge Labs, Inc. | Pande Vijay Satyanand | Directior | 2024-10-01 | Buy | 219,195 | 19.75 | 4,329,020 | 2024-10-03 19:19:49 |
| BIOA | BioAge Labs, Inc. | Cormorant Asset Management, LP | | 2024-09-27 | Buy | 450,000 | 18.00 | 8,100,000 | 2024-10-01 16:01:04 |
| BIOA | BioAge Labs, Inc. | Pande Vijay Satyanand | Directior | 2024-09-27 | Buy | 900,000 | 18.00 | 16,200,000 | 2024-09-27 16:28:00 |
| BIOA | BioAge Labs, Inc. | ENRIGHT PATRICK G | Directior | 2024-09-25 | Buy | 400,000 | 18.00 | 7,200,000 | 2024-09-27 16:26:41 |
| BIOA | BioAge Labs, Inc. | HEALY JAMES | Directior | 2024-09-25 | Buy | 666,665 | 18.00 | 11,999,970 | 2024-09-27 16:22:43 |
